EBV: Study Shows Gene-Eden-VIR is Effective Against Epstein Barr Virus

• 

We believe that even with 3,413 papers published on the anti-EBV effects of catechins like those found in Green Tea, there are many untapped opportunities for research in this area. - Mike Evans, polyDNA

Rochester, NY (PRWEB) September 01, 2013

polyDNA announces that a new clinical study found that Gene-Eden-VIR is safe and effective in reducing symptoms during an Epstein Barr Virus (EBV) infection (1). The study was published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs.

Study authors wrote that, “individuals infected with EBV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (1).” The study authors also wrote that “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (1).”

Although there are a few antiviral drugs that can treat an EBV infection, they are not licensed for clinical use according to a study published in The Journal of Microbial Chemotherapy in August of 2005 (2). Moreover, “Regimens that have been used empirically and in clinical trials have been largely ineffective, and as such have prompted the search for more effective approaches (2).”

That study’s authors went even further and wrote that “For latent infection … development of novel antiviral drugs … are among the more promising approaches (2).”

Gene-Eden-VIR was designed to target latent viruses and, during the study, polyDNA was happy to find that participants reported a decrease in their symptoms, and “no side effects after taking Gene-Eden-VIR (1).”

Mike Evans of polyDNA said, “We believe that even with 3,413 papers published on the anti-EBV effects of catechins like those found in Green Tea, there are many untapped opportunities for research in this area. Many of them need to be explored, and that’s part of polyDNA’s mission. We aim to develop natural products that are as effective as drugs.”

To view the entire paper, visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101
We invite the media to contact us for interviews at: info(at)buy-gene-eden(dot)com or phone 585-250-9999.

###

References:

(1)    http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101
(2) http://www.ncbi.nlm.nih.gov/pubmed/16006448

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

PDF Print